Previous close | 1.7000 |
Open | 2.4200 |
Bid | 2.8000 |
Ask | 2.9500 |
Strike | 30.00 |
Expiry date | 2025-01-17 |
Day's range | 2.2200 - 2.9500 |
Contract range | N/A |
Volume | |
Open interest | 2.87k |
Revenue Growth and Enhanced 2024 Guidance Highlight Guardant Health's First Quarter Achievements
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Guardant Health (GH) delivered earnings and revenue surprises of 36.11% and 11.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?